NON SMALL CELL LUNG
Clinical trials for NON SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody EPI-326 enters first human trials for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung or head & neck cancers that have specific EGFR mutations. The drug is a bispecific antibody designed to target cancer cells more precisely. The main goals are to check safety, find the r…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New lung cancer drug shows promise in early trial
Disease control Recruiting nowThis study tests a new medicine called PF-08634404, given alone or with chemotherapy, for adults with early or locally advanced non-small cell lung cancer. The trial has three parts: before surgery, after surgery if cancer remains, or after chemoradiation. Researchers will check …
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for tough cancers: veonetinib trial launches
Disease control Recruiting nowThis Phase 2 trial tests an oral drug called veonetinib (AL8326) in 80 adults with advanced small cell lung cancer, non-small cell lung cancer, or renal cell carcinoma who have already tried at least one prior treatment. The study aims to find the best dose and see if the drug ca…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for advanced cancers? pfizer launches early trial of PF-08046033
Disease control Recruiting nowThis early-stage study tests a new medicine called PF-08046033 in adults with advanced lung, esophageal, or skin cancers that have spread or can't be removed. The main goal is to check safety and find the right dose. Researchers will also look for early signs that the drug may he…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests A2B395, a donor-derived CAR T-cell therapy designed to target cancer cells while sparing healthy ones. It is for adults with advanced solid tumors like colorectal, lung, or breast cancer that have lost a specific immune marker. The trial has two phases: first to …
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
Researchers track lung cancer care in china
Knowledge-focused Recruiting nowThis study looks at medical records of 3000 people in China with early-stage non-small cell lung cancer (stages I to III). The goal is to understand what treatments patients receive, how often biomarker testing is done, and what happens to them over time. No new treatments are gi…
Matched conditions: NON SMALL CELL LUNG
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC